Charles Perkins Centre and School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia.
Department of Anatomy and Physiology, The University of Melbourne, Parkville, Victoria, Australia.
Glia. 2023 Apr;71(4):1120-1141. doi: 10.1002/glia.24329. Epub 2022 Dec 30.
The sphingolipids galactosylceramide (GalCer), sulfatide (ST) and sphingomyelin (SM) are essential for myelin stability and function. GalCer and ST are synthesized mostly from C22-C24 ceramides, generated by Ceramide Synthase 2 (CerS2). To clarify the requirement for C22-C24 sphingolipid synthesis in myelin biosynthesis and stability, we generated mice lacking CerS2 specifically in myelinating cells (CerS2 ). At 6 weeks of age, normal-appearing myelin had formed in CerS2 mice, however there was a reduction in myelin thickness and the percentage of myelinated axons. Pronounced loss of C22-C24 sphingolipids in myelin of CerS2 mice was compensated by greatly increased levels of C18 sphingolipids. A distinct microglial population expressing high levels of activation and phagocytic markers such as CD64, CD11c, MHC class II, and CD68 was apparent at 6 weeks of age in CerS2 mice, and had increased by 10 weeks. Increased staining for denatured myelin basic protein was also apparent in 6-week-old CerS2 mice. By 16 weeks, CerS2 mice showed pronounced myelin atrophy, motor deficits, and axon beading, a hallmark of axon stress. 90% of CerS2 mice died between 16 and 26 weeks of age. This study highlights the importance of sphingolipid acyl chain length for the structural integrity of myelin, demonstrating how a modest reduction in lipid chain length causes exposure of a denatured myelin protein epitope and expansion of phagocytic microglia, followed by axon pathology, myelin degeneration, and motor deficits. Understanding the molecular trigger for microglial activation should aid the development of therapeutics for demyelinating and neurodegenerative diseases.
鞘脂类神经酰胺半乳糖苷(GalCer)、硫酸脑苷脂(ST)和神经酰胺(SM)对髓鞘的稳定性和功能至关重要。GalCer 和 ST 主要由 CerS2 合成的 C22-C24 神经酰胺合成,CerS2 合成酶 2(CerS2)。为了阐明 C22-C24 鞘脂合成在髓鞘生物合成和稳定性中的需求,我们生成了髓鞘细胞中特异性缺乏 CerS2 的小鼠(CerS2 )。在 6 周龄时,CerS2 小鼠形成了正常外观的髓鞘,但髓鞘厚度和有髓神经轴突的百分比减少。CerS2 小鼠髓鞘中 C22-C24 鞘脂的明显丢失被 C18 鞘脂水平的大大增加所补偿。在 6 周龄的 CerS2 小鼠中,出现了一种明显的小胶质细胞群体,表达高水平的激活和吞噬标记物,如 CD64、CD11c、MHC Ⅱ类和 CD68,并且在 10 周龄时增加。在 6 周龄的 CerS2 小鼠中,变性髓鞘碱性蛋白的染色也明显增加。到 16 周龄时,CerS2 小鼠表现出明显的髓鞘萎缩、运动功能障碍和轴突串珠,这是轴突应激的标志。90%的 CerS2 小鼠在 16 至 26 周龄之间死亡。这项研究强调了鞘脂酰链长度对髓鞘结构完整性的重要性,表明脂质链长度的适度减少如何导致变性髓鞘蛋白表位的暴露和吞噬性小胶质细胞的扩张,随后是轴突病理学、髓鞘变性和运动功能障碍。了解小胶质细胞激活的分子触发因素应有助于开发脱髓鞘和神经退行性疾病的治疗方法。